Animal models, screening methods, and treatment methods for intraocular diseases or disorders
AssigneeSmilebiotek Zhuhai Limited
InventorsYan ZHANG, Lai WEI, Hui OUYANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmilebiotek Zhuhai Limited
InventorsYan ZHANG, Lai WEI, Hui OUYANG
Estimating the term…
Provided herein are screening methods and animal models related to intraocular diseases such as age-related macular degeneration (AMD), for example, for identifying candidate therapeutics for treating or preventing eye diseases, such as AMD. Also provided herein are compounds/compositions that are useful for killing or inhibiting the growth of a microorganism, such as Bacillus megaterium. Further provided herein are methods of using the compounds/compositions for treating infections with a microorganism, such as Bacillus megaterium and for treating or preventing diseases or disorders associated with such infections, such as AMD.
A method of treating age-related macular degeneration (AMD) in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a compound selected from compounds 1-8, or a pharmaceutically acceptable salt thereof, wherein compounds 1-8 have the following chemical structure:
A method of reducing a drusenoid lesion and/or drusen-like nodules in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a compound selected from compounds 1-8, or a pharmaceutically acceptable salt thereof, wherein compounds 1-8 have the following chemical structure:
A method of reducing activation of the complement system and/or inflammation in an eye in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a compound selected from compounds 1-8, or a pharmaceutically acceptable salt thereof, wherein compounds 1-8 have the following chemical structure:
Dependencies are inferred from the claim text.